Indefinite Delivery Contract W81K0425DA010
- Not listed
- The Defense Health Agency awarded a single-award Indefinite Delivery Contract to Greer Laboratories, Inc. (doing business as Stallergenes Greer) on June 4, 2025, with a ceiling value of $2.53M and ultimate completion date of December 3, 2025. The contract encompasses the supply of allergen extract biological products and related supplies for the United States Army Centralized Allergen Extract Laboratory (USACAEL) located at Fort Meade, Maryland. Greer Laboratories, a North Carolina-based...
- The Defense Health Agency awarded a single award indefinite delivery contract to Greer Laboratories, Inc., doing business as Stallergenes Greer, with a potential value of $7,677,969.95 to provide allergen extract vaccines and related products and services. Task orders issued against the contract include allergen extract vaccines for $260,688.06 to be delivered to Fort Meade, Maryland from September 2023 through February 2028. Additional task orders were issued for allergen extract vaccines and...
- Greer Laboratories, Inc., doing business as Stallergenes Greer, was awarded a Federal Supply Schedule contract by the Veterans Integrated Service Network 12 (VISN 12) under the Pharmaceuticals and Drugs (FSS-61-IB) General Services Administration schedule. This multiple-award, indefinite delivery vehicle carries a ceiling value of $336,420.00, with an award date of May 15, 2016, and an ultimate completion date of May 31, 2026. The contract encompasses the procurement of allergen extract...
- This federal contract IDV award from the Defense Health Agency (DHA) to Greer Laboratories, Inc. (doing business as Stallergenes Greer) is for the provision of allergen extracts, which are critical medical supplies used for allergy research, testing, and treatment at military and VA healthcare facilities. The $7,677,969.95 IDV contract, which runs through February 2028, is specifically designed to supply the U.S. Army Centralized Allergen Extract Laboratory at Fort Meade, Maryland. This...
- The Blanket Purchase Agreement was awarded on August 12, 2020 by the Defense Health Agency as a single-award contract with a potential value of $1.5 million. All-American Allergy Alternatives, LLC will provide allergy-related products to support DHA programs through August 11, 2025. No set-asides were applied to this procurement. As the healthcare component of the Department of Defense, the Defense Health Agency aims to ensure military service members and their families have access to quality...
- The Defense Health Agency (DHA) has awarded a Blanket Purchase Agreement (BPA) contract to Allergychoices LLC, a self-certified small disadvantaged business located in Onalaska, Wisconsin. The single-award Indefinite Delivery Vehicle (IDV) contract, valued at $250,000 and valid through July 31, 2028, enables the DHA to procure custom sublingual immunotherapy (SLIT) drops tailored to individual patient allergies through task orders or price lists. Allergychoices specializes in providing...
- Grifols USA LLC was awarded a $1.381 billion multiple-award Federal Supply Schedule contract on May 1, 2022, for the provision of drugs, pharmaceuticals, and hematology-related products under General Services Administration Schedule 61-IB (Pharmaceuticals and Drugs). The contract, which extends through April 30, 2027, is funded by Veterans Integrated Service Network 12 and carries no set-aside designation, indicating open competition among large businesses. Under this primary indefinite delivery...
- This is a $999,999,999 Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract serves as a primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name...
- The U.S. Air Force Air Education and Training Command (AETC) awarded a single-award Blanket Purchase Agreement (BPA) to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, to provide continued use of two IMMUNOCAP SYSTEM ANALYZERS at the Wilford Hall Ambulatory Surgical Center (WHASC) located at JBSA-Lackland, TX. This $13.8 million BPA, with a period of performance from October 2024 to April 2026, enables AETC to place task orders for the IMMUNOCAP SYSTEM ANALYZERS, as well as related...
- Government Scientific Source Inc. (UEI: J49CN39QTNW3) was awarded a single-award Indefinite Delivery Contract by the Defense Health Agency on October 1, 2025, with a ceiling value of $1,129,436.91 and ultimate completion date of September 30, 2030. The contract supplies Bio-Rad brand Unity Real Time Software licenses and quality control reagents to Madigan Army Medical Center. No set-aside was utilized for this procurement. The Defense Health Agency, which oversees the Military Health System,...
Greer Laboratories, Inc., doing business as Stallergenes Greer, was awarded a single-award indefinite delivery contract valued at $12.0 million by the Defense Health Agency on September 22, 2025, with an ultimate completion date of September 21, 2030. The contract provides allergen extract biological products, diluents, and diagnostic testing antigens in support of the United States Army Centralized Allergen Extract Laboratory (USACAEL) located at Fort Meade, Maryland. The procurement encompasses a comprehensive range of allergen extracts including tree, grass, weed, mold, food, and animal antigens, along with miscellaneous diagnostic materials and ancillary supplies such as vials and syringes. No set-aside designation was utilized for this award, allowing the contractor to compete in an open federal contracting environment. Greer Laboratories' specialized expertise in FDA-approved biologics manufacturing and compliance with United States Pharmacopeial Convention 797 guidelines made it the sole responsible source capable of meeting the agency's technical requirements. The contract supports critical medical readiness operations across the military healthcare system, with USACAEL processing approximately 100,000 vials of allergy vaccines and diagnostics annually for over 500 military and Veterans Affairs medical facilities. The original solicitation, posted by the Department of the Army Medical Command's Health Readiness Contracting Office at Joint Base San Antonio Fort Sam Houston, established a firm fixed price structure with a base year valued at $1.8 million and four option years extending through August 15, 2030. Award selection was justified under Federal Acquisition Regulation 6.302-1 (sole source authority), acknowledging that only one responsible source could satisfy the specialized technical requirements for allergen extract production and supply. The contractor's established track record of delivering allergen extract vaccines, diagnostic antigens, and related medical supplies to federal healthcare agencies, combined with demonstrated capability to supply at least 98 percent of requested allergen extracts, positioned Greer Laboratories as the essential supplier for maintaining allergy treatment and immunological research support across the Department of Defense healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 9/19/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Notice of Intent to Sole Source: Allergen Extract Supplies | W81K04-25-R-A010 | Department of the Army Medical Command | Special Notice 1/1 | 2/18/25, 10:46 AM |